🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

James Nagarajah

Radboud University Nijmegen

ORCID: 0000-0002-3555-0809

Also affiliated with Radboud University Medical Center, Düsseldorf University Hospital, Radboud Institute for Molecular Life Sciences, Heinrich Heine University Düsseldorf

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial”.

177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial

The Lancet(2024)10.1016/s0140-6736(24)01653-2
N/A
4.3DataRank · unranked
287 citations

Daniel Castellano, Ken Herrmann, Johann S. De Bono, Neal D. Shore, Kim N. +18 more

Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer

Annals of Oncology(2025)10.1016/j.annonc.2025.07.003
N/A
0.663DataRank · unranked
31 citations

K.N. Chi, Neal D. Shore, Ken Herrmann, Johann S. De Bono, Daniel Castellano +88 more

Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers

Endocrine Related Cancer(2021)10.1530/erc-21-0017
N/A
0DataRank · unranked
18 citations

Jennifer R. Cracchiolo, Gnana P. Krishnamoorthy, Luis J. Leandro‐García, James Nagarajah, Mahesh Saqcena +11 more